2015 Next Generation Dx Summit
  • ADX Final Banner
  • ADX 2014 Highlights
  • Sponsor & Exhibit
  • About the Summit

Final Agenda Released 

The Next Generation Dx Summit, entering its seventh year, brings together more than 900 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities. Spanning from clinical diagnostics to business strategy, this year’s expanded program encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer immunotherapy, and reimbursement. With widespread coverage of all the most relevant diagnostics topics, the Next Generation Dx Summit promises to be a must-attend event to hear the latest announcements and developments in this rapidly evolving field.

Conference Programs

Short Courses - View Details

  • Use of FFPE/Fixed Tissues for Clinical Research
  • Method Validation According to CLSI Guidelines
  • Practical Considerations for NGS Data Analysis and Interpretation
  • Microfluidics for Point-of-Care
  • Establishing the Value of Diagnostic Tests
  • NGS as a Diagnostics Platform
  • Detection and Characterization of Circulating Biomarkers
  • Regulatory Compliance in Molecular Diagnostics
  • Use of CLIA-Waived POC and Rapid Diagnostic Tests in Community Pharmacies
  • NGS for Infectious Disease Diagnostics
  • Regulatory and Reimbursement Considerations with NGS and Other Multiplex Assays

Attendee Testimonials

"The Next Generation Dx Summit brings together key players from all facets of diagnostic development. Its format is very conducive to networking and learning from the leaders in the field. This is a great meeting for anyone who is serious about pursuing diagnostic technologies anywhere from research to commercialization."
Program Director, Fluxion Biosciences

"The meeting was excellent, one of the best I have attended, and the standard of talks matched to the schedule across the board."
Vice President, Diagnostics, GlaxoSmithKline

 "As we begin to move from a centralized lab to a point-of-care setting we have faced many challenges. It has been a very rewarding meeting with the leaders in policy making along with the leaders in development all in the same place."
Pathology, Graves Gilbert Clinic

"Great conference! Most up to date data. Perfect amalgamation between industry, labs, clinicians and regulatory bodies. Highly recommended!"
Clinical Microbiology Fellow, NIH

View More Attendee Quotes


Stories and Videos from Next Generation Dx Summit 2014 

FDA’s Jennifer Dickey Provides a Regulatory Review of Clinical Sequencing Assays
Sunney Xie and Maximilian Diehn Discuss the Opportunities of Single Cell Sequencing

Plenary Session

In the Best Interest of the Patient: Balancing Innovation and Regulation

Co-Organized withAMP 

Elaine LyonModerator: Elaine Lyon, Ph.D., Medical Director, Molecular Genetics, ARUP (AMP 2014 President and Member, AMP Professional Relations Committee)


Jordan S. LaserJordan S. Laser, M.D., Medical Director, Pathology and Laboratory Medicine, North Shore Long Island Jewish Health System (Member, AMP Professional Relations Committee)

Jamie McDonaldJamie McDonald, MS, Licensed Genetic Counselor, Co-Director, HHT Center of Excellence; Assistant Professor, Department of Pathology, University of Utah

Stephen DayStephen P. Day, Ph.D., IVD Consultant (Member, AMP Professional Relations Committee)


Bruce QuinnModerator: Bruce Quinn, M.D., Ph.D., Senior Director, FaegreBD Consulting

The Impact of PAMA on Molecular Tests

Julie KhaniJulie Khani, Senior Vice President, American Clinical Laboratory Association


John F. WarrenJohn F. Warren, Senior Director, McDermott+Consulting LLC

Donna PolizioDonna Polizio, Senior Director, Managed Care & Reimbursement, Genomic Health

Paul W. RadenskyPaul W. Radensky, M.D., Partner, Health Products Regulation Group, McDermott Will & Emery LLP

Event Features

  • Form partnerships with major players in the evolving areas of diagnostics
  • Gain a comprehensive up-to-date view of diagnostics
  • Gather important industry announcements 
  • Network with 800+ attendees
    from around the world
  • Hear late-breaking news on LDTs and PAMA in the Plenary session
  • Connect with attendees using CHI’s Intro-Net
  • Review latest technologies in the poster competition
  • Choose from a range of in-depth short courses with topic experts
  • View innovative products and novel platforms in the exhibit hall


 2015 Prospectus 

2015 Prospectus is now available. 

Reserve your space early and SAVE!